Joshua M. Hare
Experienced in Metabolic Syndrome

Dr. Joshua M. Hare

Cardiology
University Of Miami
1611 Nw 12 Ave, 
Miami, FL 
Accepting New Patients
Offers Telehealth
Experienced in Metabolic Syndrome
University Of Miami
1611 Nw 12 Ave, 
Miami, FL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joshua Hare is a Cardiologist in Miami, Florida. Dr. Hare is rated as an Experienced provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Dilated Cardiomyopathy (DCM), Cardiomyopathy, Heart Failure with Preserved Ejection Fraction (HFpEF), Bone Marrow Aspiration, and Hormone Replacement Therapy (HRT). Dr. Hare is currently accepting new patients.

His clinical research consists of co-authoring 273 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles and participated in 1 clinical trial in the study of Metabolic Syndrome.

Specialties
Cardiology
Licenses
Internal Medicine in MD
Languages Spoken
English
French
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
AvMed
  • HMO
  • POS
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Florida Blue
  • EPO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Options
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Sunshine Health
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

UNIVERSITY OF MIAMI
1611 Nw 12 Ave, Miami, FL 33136
Other Locations
UNIVERSITY OF MIAMI
5555 Ponce De Leon Blvd, Coral Gables, FL 33146
UNIVERSITY OF MIAMI
1601 Nw 12th Ave, Miami, FL 33136

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease.
Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease.
Enrollment Status: Completed
Publish Date: September 02, 2025
Intervention Type: Other, Drug
Study Drug: Allogeneic Mesenchymal Human Stem Cells
Study Phase: Phase 1/Phase 2
Autologous Cardiac Stem Cell Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Label Pilot Study.
Autologous Cardiac Stem Cell Injection in Patients With Hypoplastic Left Heart Syndrome: An Open Label Pilot Study.
Enrollment Status: Completed
Publish Date: November 26, 2024
Intervention Type: Biological
Study Drug: C-kit+ Cells
Study Phase: Phase 1
Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)
Lomecel-B Injection in Patients With Hypoplastic Left Heart Syndrome: A Phase I/II Study (ELPIS)
Enrollment Status: Active_not_recruiting
Publish Date: October 04, 2023
Intervention Type: Biological
Study Drug: Longeveron Mesenchymal Stem Cells
Study Phase: Phase 1/Phase 2
A Phase I/II, Randomized, Placebo-controlled Comparative Study to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Bone Marrow (BM) Derived MSCs to Evaluate Cytokine Suppression in Patients With Chronic Inflammation Due to Metabolic Syndrome.
A Phase I/II, Randomized, Placebo-controlled Comparative Study to Evaluate the Safety and Potential Efficacy of Intravenous Infusion of Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Bone Marrow (BM) Derived MSCs to Evaluate Cytokine Suppression in Patients With Chronic Inflammation Due to Metabolic Syndrome.
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Biological, Other
Study Drugs: Allogeneic Umbilical Cord Tissue-Derived Mesenchymal Stem Cells (UCMSC), Bone Marrow-Derived Mesenchymal Stem Cells (BMMSC)
Study Phase: Phase 1/Phase 2
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty
Enrollment Status: Completed
Publish Date: July 14, 2021
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to EValuate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain
A Phase I/II, Randomized, Blinded and Placebo-controlled Trial to EValuate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Injection in PAtieNts With FaceTogenic Back Pain
Enrollment Status: Withdrawn
Publish Date: October 20, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 1/Phase 2
A Phase 1 Randomized, Double-blind, Placebo-controlled, Dose Escalation, Multicenter Study to Determine the Safety of Intravenous Ex-vivo Cultured Adult Human Mesenchymal Stem Cells (Provacel) Following Acute Myocardial Infarction
A Phase 1 Randomized, Double-blind, Placebo-controlled, Dose Escalation, Multicenter Study to Determine the Safety of Intravenous Ex-vivo Cultured Adult Human Mesenchymal Stem Cells (Provacel) Following Acute Myocardial Infarction
Enrollment Status: Completed
Publish Date: March 10, 2020
Intervention Type: Biological
Study Phase: Phase 1
A Phase I, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Treatment Resistant Depression.
A Phase I, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion Versus Placebo in Patients With Treatment Resistant Depression.
Enrollment Status: Terminated
Publish Date: April 01, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

273 Total Publications

Cardiomyocyte-specific expression of HIF-1α mediates the cardioprotective effects of Growth Hormone Releasing Hormone (GHRH).
Cardiomyocyte-specific expression of HIF-1α mediates the cardioprotective effects of Growth Hormone Releasing Hormone (GHRH).
Journal: bioRxiv : the preprint server for biology
Published: July 17, 2025
Similar Doctors
Distinguished in Metabolic Syndrome
Dr. Yale M. Cohen
Cardiology
Distinguished in Metabolic Syndrome
Dr. Yale M. Cohen
Cardiology

Cardiac And Veinworx LLC

3702 Washington St, Suite 305, 
Hollywood, FL 
 (14.7 miles away)
954-983-8910
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Yale Cohen is a Cardiologist in Hollywood, Florida. Dr. Cohen is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Metabolic Syndrome, Angina, Hypertension, and Glucocorticoid-Remediable Aldosteronism. Dr. Cohen is currently accepting new patients.

Distinguished in Metabolic Syndrome
Dr. Eliezer Hernandez
Cardiology
Distinguished in Metabolic Syndrome
Dr. Eliezer Hernandez
Cardiology

Elite Imaging LLC

5051 S Congress Ave, Akumin Lake Worth, 
Lake Worth, FL 
 (56.6 miles away)
561-795-5558
Languages Spoken:
English, French, Haitian Creole, Spanish
See accepted insurances
Accepting New Patients

Eliezer Hernandez is a Cardiologist in Lake Worth, Florida. Dr. Hernandez is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Stable Angina, Metabolic Syndrome, Fainting, and Angina. Dr. Hernandez is currently accepting new patients.

Distinguished in Metabolic Syndrome
Dr. Victor Pazos
Cardiology
Distinguished in Metabolic Syndrome
Dr. Victor Pazos
Cardiology
7100 W 20th Ave, Suite G166, 
Hialeah, FL 
 (9.6 miles away)
305-835-0551
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Victor Pazos is a Cardiologist in Hialeah, Florida. Dr. Pazos is rated as a Distinguished provider by MediFind in the treatment of Metabolic Syndrome. His top areas of expertise are Heart Murmurs, Metabolic Syndrome, Angina, and Familial Neurocardiogenic Syncope. Dr. Pazos is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hare's expertise for a condition
ConditionClose
View All 20 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile